Filtros de búsqueda

Lista de obras de

A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels

artículo científico publicado en 2008

A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.

artículo científico publicado en 2014

A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients

artículo científico publicado en 2014

A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer

artículo científico publicado en 2003

A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection

artículo científico publicado en 2017

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

artículo científico publicado en 2014

Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury

artículo científico publicado en 2020

Absence of chronic hepatitis E in a German cohort of common variable immunodeficiency patients

artículo científico

Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.

artículo científico publicado en 2008

Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence

artículo científico publicado en 2017

Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)

article

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

artículo científico publicado en 2015

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

artículo científico publicado en 2015

Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.

artículo científico publicado en 2018

Angiopoietin-2 in acute liver failure

artículo científico publicado en 2012

Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients

scientific article published on 01 March 2006

Anti-HDV IgM as a marker of disease activity in hepatitis delta

artículo científico publicado en 2014

Anti-Hdv Immunoglobulin M Testing in Hepatitis Delta Revisited: Correlations with Disease Activity and Response to Pegylated Interferon-α2A Treatment ⬇️

artículo científico publicado el 24 de octubre de 2011

Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro

artículo científico publicado en 2012

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication

artículo científico publicado en 2016

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues

artículo científico publicado en 2010

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

artículo científico publicado en 2005

Antiviral therapy of hepatitis delta virus infection - progress and challenges towards cure

artículo científico publicado en 2016

Antiviral treatment and liver-related complications in hepatitis delta

artículo científico publicado en 2016

Apolipoprotein E polymorphisms and their protective effect on hepatitis E virus replication

artículo científico publicado en 2016

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

artículo científico publicado en 2016

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

artículo científico publicado en 2015

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis

artículo científico publicado en 2012

Author Correction: Development and performance of prototype serologic and molecular tests for hepatitis delta infection

artículo científico publicado en 2020

Autoimmune hepatitis and overlap syndromes

artículo científico publicado en 2002

Autoimmune hepatitis induction can occur in the liver

scientific article published on 01 December 2019

Automated low-flow ascites pump in a real-world setting: complications and outcomes

scientific article published on 01 September 2018

Automated nucleic acid isolation methods for HDV viral load quantification can lead to viral load underestimation

artículo científico publicado en 2019

Autophagy alleviates amiodarone-induced hepatotoxicity

artículo científico publicado en 2020

Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.

artículo científico publicado en 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

artículo científico publicado en 2015

Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta

artículo científico publicado en 2019

Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection

scientific article published on February 2009

Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?

artículo científico publicado en 2004

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

artículo científico publicado en 2006

Characterization of two types of intranuclear hepatocellular inclusions in NAFLD

scientific article published on 06 October 2020

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study

article

Chronic Hepatitis E is associated with cholangitis

artículo científico publicado en 2019

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

artículo científico publicado en 2018

Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.

artículo científico publicado en 2014

Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells

artículo científico publicado en 2019

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response

artículo científico publicado en 2007

Clinical Impact of Liver Biopsies in Liver Transplant Recipients.

artículo científico publicado en 2017

Clinical and Virological Aspects of HBV Reactivation: A Focus on Acute Liver Failure

scientific article published on 16 September 2019

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

artículo científico publicado en 2017

Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies

artículo científico publicado en 2017

Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI) ⬇️

artículo científico publicado el 24 de marzo de 2011

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions

artículo científico publicado en 2012

Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy

artículo científico publicado en 2009

Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients

artículo científico publicado en 2018

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

artículo científico publicado en 2016

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

artículo científico publicado en 2016

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study

artículo científico publicado en 2017

Comprehensive Evaluation of Hepatitis E Serology and Molecular Testing in a Large Cohort

scientific article published on 19 February 2020

Comprehensive phenotyping of regulatory T cells after liver transplantation.

artículo científico publicado en 2015

Compromised function of natural killer cells in acute and chronic viral hepatitis.

artículo científico publicado en 2013

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients

artículo científico publicado en 2018

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

artículo científico publicado en 2020

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

artículo científico publicado en 2011

Cost of treating hepatitis C in Germany: a retrospective multicenter analysis

artículo científico publicado en 2014

Creating an effective clinical registry for rare diseases

artículo científico publicado en 2016

Current recommendations for the treatment of chronic hepatitis C

artículo científico publicado en 2014

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells.

artículo científico publicado en 2015

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.

artículo científico publicado en 2009

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections

artículo científico publicado en 2017

DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional Therapies

artículo científico publicado en 2020

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

artículo científico publicado en 2016

Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients

artículo científico publicado en 2013

Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E

scientific article published on 14 June 2019

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

artículo científico publicado en 2013

Development and performance of prototype serologic and molecular tests for hepatitis delta infection

artículo científico publicado en 2018

Devil hepatitis D: an orphan disease or largely underdiagnosed?

scientific article published on 27 October 2018

Diagnosis and Treatment of Acute Hepatitis C Virus Infection ⬇️

artículo científico publicado el 1 de diciembre de 2012

Diet-refractory NASH in an elderly woman

artículo científico publicado en 2020

Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease ⬇️

artículo científico publicado el 27 de enero de 2011

Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens

artículo científico publicado en 2019

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma

artículo científico publicado en 2006

Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.

artículo científico publicado en 2016

Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?

artículo científico publicado en 2018

Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?

artículo científico publicado en 2008

Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study

scientific article published on 01 September 2018

Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.

artículo científico publicado en 2015

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

artículo científico publicado en 2011

Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.

artículo científico publicado en 2006

E-xchange: Hepatitis E and the Risk of Plasma Products for Organ Transplant Recipients

artículo científico publicado en 2018

EASL Recognition Awardee for 2014: Prof. Geoff-Dusheiko

artículo científico publicado en 2014

EASL transitioning into the new decade

article by Heiner Wedemeyer published 29 October 2009 in Journal of Hepatology

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

artículo científico publicado en 2006

Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.

artículo científico publicado en 2010

Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.

artículo científico publicado en 2009

Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis

artículo científico publicado en 2014

Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry

article

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals

artículo científico publicado en 2014

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial ⬇️

artículo científico publicado el 4 de agosto de 2013

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.

artículo científico publicado en 2011

Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection

artículo científico publicado en 2014

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

artículo científico publicado en 2015

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting

artículo científico publicado en 2013

Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses

scientific article published on 08 July 2019

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study

scientific article published on 26 October 2011

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

artículo científico publicado en 2014

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

article

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.

artículo científico publicado en 2011

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

artículo científico publicado en 2010

Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis

artículo científico publicado en 2007

Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics

artículo científico publicado en 2010

Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection

scientific article published on 02 December 2019

Evaluation of sound speed for detection of liver fibrosis: prospective comparison with transient dynamic elastography and histology

artículo científico publicado en 2010

Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.

artículo científico publicado en 2015

Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy

artículo científico publicado en 2012

Exacerbation d’infection par le virus de l’hépatite E au cours d’un traitement par anti-TNFα

Exacerbation of hepatitis E virus infection during anti-TNFα treatment

artículo científico publicado en 2016

Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

artículo científico publicado en 2007

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

artículo científico publicado en 2015

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Flares during long-term entecavir therapy in chronic hepatitis B.

artículo científico publicado en 2016

Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection

artículo científico publicado en 2009

Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.

artículo científico publicado en 2015

Frequent detection of HCV RNA and HCVcoreAg in stool of patients with chronic hepatitis C.

artículo científico publicado en 2016

From volcano clouds to iLivers: EASL growing in times of change

artículo científico publicado en 2011

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.

artículo científico publicado en 2007

GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients

artículo científico publicado en 2008

Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice

artículo científico publicado en 2010

Gilbert's syndrome and antiviral therapy of hepatitis C.

artículo científico publicado en 2009

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

artículo científico publicado en 2018

Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts

artículo científico publicado en 2020

Glucocorticosteroids increase cell entry by hepatitis C virus

artículo científico publicado en 2010

Grazoprevir, Ruzasvir, and Uprifosbuvir for HCV After NS5A Treatment Failure

artículo científico publicado en 2017

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination

artículo científico publicado en 2020

HBV-infections in Germany - health care costs in a real-life-setting

artículo científico publicado en 2017

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

artículo científico publicado en 2012

HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection

scientific article published on 18 July 2018

HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals

artículo científico publicado en 2014

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

artículo científico publicado en 2017

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

artículo científico publicado en 2018

HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis.

artículo científico publicado en 2011

HDV infection rates in northern Vietnam

artículo científico publicado en 2018

HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E.

artículo científico publicado en 2014

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level

artículo científico publicado en 2020

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.

artículo científico publicado en 2006

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

artículo científico publicado en 2011

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

artículo científico publicado en 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

artículo científico publicado en 2012

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

scientific article published on 28 June 2011

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

artículo científico publicado en 2007

Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response

artículo científico publicado en 2006

Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes

artículo científico publicado en 2020

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

article

Hepatitis B virus: where are we and where are we going?

artículo científico publicado en 2004

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

artículo científico publicado en 2016

Hepatitis C and metabolic disorders: genetics, mechanism, and therapies (clinical and experimental)

artículo científico publicado en 2012

Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?

artículo científico

Hepatitis C virus infection from the perspective of heterologous immunity.

artículo científico publicado en 2016

Hepatitis C virus living off the fat of the land

artículo científico publicado en 2008

Hepatitis C virus mutation affects proteasomal epitope processing

artículo científico publicado en 2004

Hepatitis D revival

scientific article published on January 2011

Hepatitis D virus infection--not a vanishing disease in Europe!

artículo científico publicado en 2007

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

artículo científico publicado en 2011

Hepatitis E - More than a Rare Travel-Associated Infectious Disease!

artículo científico publicado en 2017

Hepatitis E In Transplant Recipients: Why Is This Not A Problem In Japan?

artículo científico publicado en 2015

Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection

artículo científico publicado en 2016

Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy

artículo científico publicado en 2019

Hepatitis E Virus Mutations: Functional and Clinical Relevance

artículo científico publicado en 2016

Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays

artículo científico publicado en 2015

Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder

artículo científico publicado en 2017

Hepatitis E in Germany--an under-reported infectious disease

artículo científico publicado en 2014

Hepatitis E seroprevalence in the Americas: A systematic review and meta-analysis.

artículo científico publicado en 2018

Hepatitis E vaccination—is HEV 239 the breakthrough? ⬇️

artículo científico publicado el 1 de enero de 2011

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

artículo científico publicado en 2012

Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E.

artículo científico publicado en 2017

Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany

scientific article published on 01 September 2020

Hepatitis E virus infection

artículo científico publicado en 2017

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

artículo científico publicado en 2010

Hepatitis E virus infection: multiple faces of an underestimated problem

artículo científico publicado en 2012

Hepatitis E virus replication and interferon responses in human placental cells.

artículo científico publicado en 2018

Hepatitis delta and HIV infection

artículo científico

Hepatitis delta virus

scientific article published on 20 April 2011

Hepatitis delta: immunopathogenesis and clinical challenges

artículo científico publicado en 2010

Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication

artículo científico publicado en 2012

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation

artículo científico publicado en 2020

High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis ⬇️

artículo científico publicado el 13 de enero de 2012

High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam

artículo científico publicado en 2013

High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting

artículo científico publicado en 2014

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection

artículo científico publicado en 2004

High-resolution determination of human immune cell signatures from fine-needle liver aspirates

artículo científico publicado en 2015

Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis

artículo científico publicado en 2017

How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides

artículo científico publicado en 2010

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist

artículo científico publicado en 2015

How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.

artículo científico publicado en 2014

Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses

artículo científico publicado en 2012

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.

artículo científico publicado en 2018

Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis

artículo científico publicado en 2012

Immunopathogenesis of Hepatitis E Virus Infection ⬇️

artículo científico publicado el 5 de abril de 2013

Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma

artículo científico publicado en 2004

Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles ⬇️

artículo científico publicado el 1 de junio de 2011

Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany

article

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

artículo científico publicado en 2011

Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy

artículo científico publicado en 2014

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients

artículo científico publicado en 2012

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

artículo científico publicado en 2015

Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis

artículo científico publicado en 2015

In reply

artículo científico publicado en 2015

In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity.

artículo científico publicado en 2014

In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors

artículo científico publicado en 2014

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

artículo científico publicado en 2016

Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.

artículo científico publicado en 2014

Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

artículo científico publicado en 2016

Increased HEV seroprevalence in patients with autoimmune hepatitis

artículo científico publicado en 2014

Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss.

artículo científico publicado en 2018

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

artículo científico publicado en 2005

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

article

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis

artículo científico publicado en 2018

Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI) ⬇️

artículo científico publicado el 22 de marzo de 2013

Influenza virus infection as precipitating event of acute-on-chronic liver failure

scientific article published on 08 January 2019

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

artículo científico publicado en 2003

Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection

artículo científico publicado en 2009

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

artículo científico publicado en 2012

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

artículo científico publicado en 2010

Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up

artículo científico publicado en 2017

Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

artículo científico publicado en 2017

Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials

artículo científico

Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.

artículo científico publicado en 2017

Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis

artículo científico publicado en 2009

Intranuclear inclusions in hepatocellular carcinoma contain autophagy-associated proteins and correlate with prolonged survival

artículo científico publicado en 2019

Irreversible impact of chronic hepatitis C virus infection on human natural killer cell diversity

scientific article published on 25 July 2018

Is there a need for liver disease monitoring in HIV patients in Africa?

artículo científico publicado en 2011

Is there sufficient evidence to recommend antiviral therapy in hepatitis C?

artículo científico

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

artículo científico publicado en 2010

Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis

artículo científico publicado en 2008

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

artículo científico publicado en 2014

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

artículo científico publicado en 2016

Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis

artículo científico publicado en 2020

Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis-Authors' reply.

artículo científico publicado en 2018

Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population

artículo científico publicado en 2014

Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.

artículo científico publicado en 2014

Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort

scientific article published on 08 April 2020

Liver stiffness measurements and short-term survival after left ventricular assist device implantation: A pilot study

artículo científico publicado en 2015

Liver transplantation: A new risk factor for intestinal intussusceptions ⬇️

artículo científico publicado el 1 de enero de 2011

Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals

artículo científico publicado en 2018

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

artículo científico publicado en 2010

Long-term follow-up after successful interferon therapy of acute hepatitis C.

artículo científico publicado en 2004

Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study.

artículo científico publicado en 2017

Long-term study of hepatitis D infection at secondary care centers: the impact of viremia on liver-related outcomes

artículo científico publicado en 2020

Longer survival of liver transplant recipients with hepatitis virus coinfections

artículo científico publicado en 2007

Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis

artículo científico publicado en 2019

Low Risk of Developing Chronic Hepatitis E in Heart Transplant Recipients: A Prospective 2-Year Follow-Up Study

artículo científico publicado en 2016

Major depression and liver disease: the role of microbiome and inflammation

artículo científico publicado en 2018

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

artículo científico publicado en 2016

Managing HBV in patients with impaired immunity

artículo científico publicado en 2010

Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care?

scientific article published on 31 March 2008

Membranous Budd–Chiari syndrome in Caucasians

artículo científico publicado en 2010

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

artículo científico publicado en 2016

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators

artículo científico publicado en 2015

Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses

artículo científico publicado en 2009

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.

artículo científico publicado en 2017

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level

scientific article published on 12 February 2019

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

artículo científico publicado en 2009

NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization

scientific article published on 29 July 2019

NK cells in hepatitis C: role in disease susceptibility and therapy.

artículo científico

Natural history of acute and chronic hepatitis C ⬇️

artículo científico publicado el 1 de agosto de 2012

Natural history: the importance of viral load, liver damage and HCC.

scientific article published on January 2008

Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients

artículo científico publicado en 2019

New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye: Table 1 ⬇️

artículo científico publicado el 30 de agosto de 2012

Nitazoxanide for the treatment of chronic hepatitis C new opportunities but new challenges?

artículo científico publicado en 2009

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

scientific article published in PLoS ONE

No increased incidence for GB-virus C infection in a cohort of HIV-positive lymphoma patients

artículo científico publicado en 2010

Non-invasive fibrosis score for hepatitis delta.

artículo científico publicado en 2016

Noninvasive Models for Predicting Liver Fibrosis in Individuals with Hepatitis D Virus/Hepatitis B Virus Coinfection in the Brazilian Amazon Region

scientific article published on 18 May 2020

Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy

artículo científico publicado en 2016

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

artículo científico publicado en 2015

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C

artículo científico publicado en 2014

Pathogenesis and Treatment of Hepatitis E Virus Infection ⬇️

artículo científico publicado el 1 de mayo de 2012

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

artículo científico publicado en 2017

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data

scientific article published on 01 January 2019

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

scientific article published on 01 March 2019

Peginterferon plus adefovir versus either drug alone for hepatitis delta

scientific article published on 01 January 2011

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis

artículo científico publicado el 1 de enero de 2012

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes

artículo científico publicado en 2002

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting

artículo científico publicado en 2015

Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay

artículo científico publicado en 2009

Performance of Roche qualitative HEV assay on the cobas 6800 platform for quantitative measurement of HEV RNA

artículo científico publicado en 2020

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

artículo científico publicado en 2014

Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver

artículo científico publicado en 2008

Polyethylene glycol-interferon: current status in hepatitis C virus therapy

artículo científico publicado en 2002

Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam

artículo científico publicado en 2017

Prevalence of HBV genotypes in Central and Eastern Europe

scientific article published on 01 October 2008

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review

artículo científico publicado en 2020

Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome

artículo científico publicado en 2009

Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure

artículo científico publicado en 2008

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus

artículo científico publicado en 2011

Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice

artículo científico publicado en 2019

Propel: A Randomized Trial of Mericitabine Plus Peginterferon Alpha-2a/Ribavirin Therapy in Treatment-NaïVe HCV Genotype 1/4 Patients ⬇️

artículo científico publicado el 26 de junio de 2013

Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012

artículo científico publicado en 2018

Proteoglycans act as cellular hepatitis delta virus attachment receptors

artículo científico publicado en 2013

Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a

artículo científico publicado en 2019

Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis

artículo científico publicado en 2009

Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

artículo científico publicado en 2019

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation

artículo científico publicado en 2011

Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV.

artículo científico publicado en 2010

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

scientific article published on 04 August 2020

Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.

artículo científico publicado en 2017

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis

scientific article published on 13 February 2020

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.

artículo científico publicado en 2017

Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis

artículo científico publicado en 2016

Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents

artículo científico publicado en 2012

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2013

Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C.

artículo científico publicado en 2011

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters

artículo científico publicado en 2014

Reply to Letter to the Editor

artículo científico publicado en 2017

Reply to the Letter to the Editor: "Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma"

artículo científico publicado en 2020

Reply to: "HCV RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin".

artículo científico publicado en 2016

Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice

artículo científico publicado en 2009

Republished paper: Managing HBV in patients with impaired immunity

artículo científico publicado en 2011

Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study

artículo científico publicado en 2020

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

scientific article published on 12 May 2020

Results of single‐center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin ⬇️

artículo científico publicado el 3 de abril de 2013

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

artículo científico publicado en 2014

Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience

artículo científico publicado en 2013

Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis

artículo científico publicado en 2015

Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study

artículo científico publicado en 2020

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients

scientific article published on 06 August 2008

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease

scientific article published on 23 November 2010

Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta

artículo científico publicado en 2013

Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection

artículo científico publicado en 2019

SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients

scientific article published on 11 July 2019

SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.

artículo científico publicado en 2017

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.

artículo científico publicado en 2016

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

artículo científico publicado en 2019

Safety and performance of liver biopsies in liver transplant recipients

artículo científico publicado en 2014

Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis

artículo científico publicado en 2017

Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

artículo científico publicado en 2016

Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.

artículo científico publicado en 2009

Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.

artículo científico publicado en 2017

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

artículo científico publicado en 2004

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

scientific article published on 23 October 2019

Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study

artículo científico publicado en 2020

Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

scientific article published on 18 September 2020

Soluble immune markers in the different phases of chronic hepatitis B virus infection

scientific article published on 01 October 2019

Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?

artículo científico publicado en 2008

Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse

artículo científico publicado en 2005

Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis

artículo científico publicado en 2020

Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?

artículo científico publicado en 2017

Structural barriers in the context of opiate substitution treatment in Germany - a survey among physicians in primary care ⬇️

artículo científico publicado el 22 de julio de 2013

Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

artículo científico publicado en 2010

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

artículo científico publicado en 2018

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients

scientific article published on 31 July 2019

Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir.

artículo científico publicado en 2017

Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient

artículo científico publicado en 2007

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis

artículo científico publicado en 2007

Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program.

artículo científico publicado en 2014

Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity

artículo científico publicado en 2015

Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases

artículo científico publicado en 2018

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

artículo científico publicado en 2014

Telomerase gene mutations are associated with cirrhosis formation

artículo científico publicado en 2011

Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

scientific article published on 24 July 2020

The Effect of Immunosuppression on Coagulation After Liver Transplantation

scientific article published on 30 May 2019

The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

scientific article published on 04 August 2020

The German network of excellence for viral hepatitis (Hep-Net)

scientific article published on 01 September 2003

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection

artículo científico publicado en 2008

The New Era of Interferon-Free Treatment of Chronic Hepatitis C

artículo científico publicado en 2015

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.

artículo científico publicado en 2016

The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients

artículo científico publicado en 2018

The burden of hepatitis D - defogging the epidemiological horizon

artículo científico publicado en 2020

The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C

artículo científico publicado en 2010

The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease

artículo científico publicado en 2018

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

artículo científico publicado en 2011

The hepatitis E virus: a likely cause of extrahepatic diseases!

artículo científico publicado en 2016

The impact of hepatitis E in the liver transplant setting

artículo científico

The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients

artículo científico publicado en 2019

The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation

article

The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase

artículo científico publicado en 2008

The widespread rarity of HBsAg loss in chronic hepatitis B

scientific article published on 22 January 2019

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

artículo científico publicado en 2008

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.

artículo científico publicado en 2009

Towards interferon-free treatment for all HCV genotypes

artículo científico publicado en 2015

Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis

artículo científico publicado en 2020

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

artículo científico publicado en 2018

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.

artículo científico publicado en 2015

Treatment Options for Hepatitis Delta Virus Infection ⬇️

artículo científico publicado el 1 de febrero de 2013

Treatment duration in acute hepatitis C: the issue is not solved yet

artículo científico publicado en 2006

Treatment of HBV/HCV coinfection

scientific article published on April 2010

Treatment of acute hepatitis C-how to explain the differences?

artículo científico publicado en 2006

Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.

artículo científico publicado en 2008

Treatment of chronic hepatitis B and the implications of viral resistance to therapy

artículo científico publicado en 2008

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

artículo científico publicado en 2002

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

artículo científico publicado en 2016

Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.

artículo científico publicado en 2003

Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step

artículo científico publicado en 2004

Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin

artículo científico publicado en 2007

Treatment of hepatitis Delta

scientific article published on 20 December 2013

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA

artículo científico publicado en 2014

Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers

scientific article published on 01 August 2019

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study

artículo científico publicado en 2005

Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R)

artículo científico publicado en 2020

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2016

Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.

artículo científico publicado en 2015

UEG Week Vienna 2014 cutting edge symposium: Today's Science, Tomorrow's Medicine session features the immune system - a driving force in digestive health and disease

artículo científico publicado en 2014

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma

scientific article published on 18 February 2020

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy

artículo científico publicado en 2019

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.

artículo científico publicado en 2016

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

artículo científico publicado en 2012

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C

artículo científico publicado en 2004

[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]

scientific article published on 14 January 2019

[In Process Citation]

artículo científico publicado en 2014

[Joint opinion of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Daclatasvir-benefit assessment according to § 35a SGB V the G-BA]

artículo científico publicado en 2015

[Limits of the G-DRG system to reflect Complexity in German University Hospitals]

artículo científico publicado en 2020

[Prognostic significance and economic burden of hepatic encephalopathy in liver cirrhosis in German hospitals based on G-DRG data]

scientific article published on 20 December 2019

[Virus hepatitis: prevalence disease with many manifestations]

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda